Statin treatment and mortality in community-dwelling frail older patients with diabetes mellitus: A retrospective observational study

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Pilotto, Alberto ^a,b   Panza, Francesco ^c,d   Copetti, Massimiliano ^d   Simonato, Matteo ^b   Sancarlo, Daniele ^d   Gallina, Pietro ^e   Strandberg, Timo ^f,g   Cruz Jentoft, Alfonso ^h   Daragjati, Julia ^b   Ferrucci, Luigi ⁱ   Fontana, Andrea ^d   Maggi, Stefania ^j   Mattace Raso, Francesco ^k   Paccalin, Marc ^l   Polidori, Maria Cristina ^m   Schulz, Ralf Joachim ^m   Topinkova, Eva ⁿ   Trifirò, Gianluca ^k,o   Welmer, Anna Karin ^p  

^a Department of OrthoGeriatrics Rehabilitation and Stabilization Frailty Area National Relevance and High Specialization Hospital   (Italy)

^b S ANTONIO HOSPITAL   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^e UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^f UNIVERSITY OF HELSINKI   (Finland)

^g UNIVERSITY OF OULU   (Finland)

^h HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁱ NATIONAL INSTITUTE ON AGING   (United States)

^j CNR   (Italy)

^k ERASMUS MEDICAL CENTER   (Netherlands)

^l POITIERS UNIVERSITY HOSPITAL   (France)

^m UNIVERSITY OF COLOGNE   (Germany)

ⁿ CHARLES UNIVERSITY   (Czech Republic)

^o UNIVERSITY OF MESSINA   (Italy)

^p KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGE; AGED; ARTICLE; COMMUNITY LIVING; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FRAIL ELDERLY; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NURSING HOME; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; VERY ELDERLY; DAILY LIFE ACTIVITY; GERIATRIC ASSESSMENT; HEALTH STATUS INDICATOR; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; FRAIL ELDERLY; GERIATRIC ASSESSMENT; HEALTH STATUS INDICATORS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84938340869     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130946     Document Type: Article

References (30)

1. Strandberg TE, Kolehmainen L, Vuorio A. Evaluation and treatment of older patients with hypercholesterolemia: a clinical review. JAMA. 2014; 312:1136-1144. doi: 10.1001/jama.2014.10924 PMID: 25226479
2. Afilalo J, Duque G, Steele R, Jukema JW, de Craen AJ, Eisenberg MJ. Statins for secondary prevention in elderly patients: a hierarchical Bayesian meta-analysis. J Am Coll Cardiol. 2008; 51:37-45. doi: 10.1016/j.jacc.2007.06.063 PMID: 18174034
3. Savarese G, Gotto AM Jr, Paolillo S, D'Amore C, Losco T, Musella F, et al. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis. J Am Coll Cardiol. 2013; 62:2090-2099. doi: 10.1016/j.jacc.2013.07.069 PMID: 23954343
4. Morley JE, Mahon G. Statins and the nursing home. J Am Med Dir Assoc. 2013; 14:853-854. doi: 10.1016/j.jamda.2013.09.016 PMID: 24286708
5. Culver AL, Ockene IS, Balasubramanian R, Olendzki BC, Sepavich DM, Wactawski-Wende J, et al. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med. 2012; 172:144-152. doi: 10.1001/archinternmed.2011.625 PMID: 22231607
6. Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: An analysis from the Jupiter trial. Lancet. 2012; 380:565-571. doi: 10.1016/S0140-6736(12)61190-8 PMID: 22883507
7. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010; 375:735-742. doi: 10.1016/S0140-6736(09)61965-6 PMID: 20167359
8. Olafsdottir E, Aspelund T, Sigurdsson G, Thorsson B, Eiriksdottir G, Harris TB, et al. Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik Study. BMJ Open. 2011; 1:e000132. doi: 10.1136/bmjopen-2011-000132 PMID: 22021772
9. LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Newman AB, Kooperberg CL, et al. Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women's Health Initiative Observational Study. J Gerontol A Biol Sci Med Sci. 2008; 63:369-375. PMID: 18426960
10. Gray SL, Aragaki AK, LaMonte MJ, Cochrane BB, Kooperberg C, Robinson JG, et al. Statins, angiotensin-converting enzyme inhibitors and physical performance in women. J Am Geriatr Soc. 2012; 60:2206-2214. doi: 10.1111/jgs.12029 PMID: 23176078
11. Lee DSH, Markwardt S, Goeres L, Lee CG, Eckstrom E, Williams C, et al. Statins and physical acitivity in older men. The Osteoporotic Fractures in Men Study. JAMA Intern Med. 2014; 174:1263-1270. doi: 10.1001/jamainternmed.2014.2266 PMID: 24911216
12. Gnjidic D, Le Couteur DG, Blyth FM, Travison T, Rogers K, Naganathan V, et al. Statin use and clinical outcomes in older men: a prospective population-based study. BMJ Open. 2013; 3.pii:e002333.
13. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010; 375:2215-2222. doi: 10.1016/S0140-6736(10)60484-9 PMID: 20609967
14. Cholesterol Treatment Trialists' Collaborators. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008 371:117-125. doi: 10.1016/S0140-6736(08)60104-X PMID: 18191683
15. European Association for Cardiovascular Prevention & Rehabilitation; ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011; 32:1769-1818. doi: 10.1093/eurheartj/ehr158 PMID: 21712404
16. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129(25 Suppl 2):S1-45. doi: 10.1161/01.cir.0000437738.63853.7a PMID: 24222016
17. Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: a systematic review. JAMA. 2012; 307:182-192. doi: 10.1001/jama.2011.1966 PMID: 22235089
18. Clegg A, Young J, Iliffe S, Olde Rikkert M, Rockwood K. Frailty in elderly people. Lancet. 2013; 381:752-762. doi: 10.1016/S0140-6736(12)62167-9 PMID: 23395245
19. Pilotto A, Ferrucci L, Franceschi M, D'Ambrosio LP, Scarcelli C, Cascavilla L, et al. Development and validation of a multidimensional prognostic index for 1-year mortality from the comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res. 2008; 11:151-161. doi: 10.1089/rej.2007.0569 PMID: 18173367
20. Pilotto A, Gallina P, Fontana A, Sancarlo D, Bazzano S, Copetti M, et al. Development and Validation of a Multidimensional Prognostic Index for Mortality Based on a Standardized Multidimensional Assessment Schedule (MPI-SVaMA) in Community-dwelling Older Subjects. J Am Med Dir Assoc. 2013; 14:287-292. doi: 10.1016/j.jamda.2013.01.005 PMID: 23402948
21. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007; 335:806-808. PMID: 17947786
22. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004; 23:2109-2123. PMID: 15211606
23. Yanovitzky I, Zanutto E, Hornik R. Estimating causal effects of public health education campaigns using propensity score methodology. Eval Progr Plann. 2005 28:209-220.
24. Jacobs JM, Cohen A, Ein-Mor E, Stessman J. Cholesterol, statins, and longevity from age 70 to 90 years. J Am Med Dir Assoc. 2013; 14:883-888. doi: 10.1016/j.jamda.2013.08.012 PMID: 24094647
25. Morley JE. The cholesterol conundrum. J Am Geriatr Soc. 2011; 59:1955-1956. doi: 10.1111/j.1532-5415.2011.03594.x PMID: 22091506
26. Fontana L, Addante F, Copetti M, Paroni G, Fontana A, Sancarlo D, et al. Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients. Aging Cell. 2013; 12:459-466. doi: 10.1111/acel.12068 PMID: 23496093
27. Siontis GC, Tzoulaki I, Ioannidis JP. Predicting death: an empirical evaluation of predictive tools for mortality. Arch Intern Med. 2011; 171:1721-1726. doi: 10.1001/archinternmed.2011.334 PMID: 21788535
28. Pilotto A, Rengo F, Marchionni N, Sancarlo D, Fontana A, Panza F, et al FIRI-SIGG Study Group. Comparing the prognostic accuracy for all-cause mortality of the Frailty Instruments: a multicentre 1-year follow-up in hospitalized older patients. PLOS ONE 2012; 7:e29090. doi: 10.1371/journal.pone.0029090 PMID: 22247767
29. Anglemyer A, Horvath HT, Bero L. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Cochrane Database Syst Rev 2014; 4:MR000034.
30. Parikh S, Shrank WH, Mogun H, Choudhry NK. Statin utilization in nursing home patients after cardiac hospitalization. J Gen Intern Med. 2010; 25:1293-1219. doi: 10.1007/s11606-010-1473-z PMID: 20714821